Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Biological Evolution | 2 | 2017 | 641 | 0.91 | Why? |
| Myxoma virus | 1 | 2019 | 5 | 0.81 | Why? |
| Aesculus | 1 | 2017 | 1 | 0.71 | Why? |
| Eukaryota | 1 | 2017 | 31 | 0.70 | Why? |
| Pseudomonas syringae | 1 | 2017 | 6 | 0.70 | Why? |
| Microbiota | 2 | 2017 | 1240 | 0.65 | Why? |
| Ecology | 1 | 2017 | 140 | 0.64 | Why? |
| Plant Diseases | 1 | 2017 | 84 | 0.63 | Why? |
| Reproduction | 1 | 2018 | 259 | 0.59 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.56 | Why? |
| Selection, Genetic | 2 | 2021 | 691 | 0.56 | Why? |
| United Nations | 1 | 2017 | 367 | 0.54 | Why? |
| Models, Theoretical | 9 | 2021 | 6659 | 0.45 | Why? |
| Blood Banks | 1 | 2017 | 535 | 0.43 | Why? |
| Climate Change | 2 | 2020 | 901 | 0.40 | Why? |
| Models, Biological | 3 | 2021 | 4907 | 0.37 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.37 | Why? |
| Communicable Diseases, Emerging | 2 | 2020 | 2523 | 0.32 | Why? |
| Epidemics | 5 | 2021 | 6407 | 0.31 | Why? |
| Demography | 3 | 2017 | 1660 | 0.30 | Why? |
| Disease Vectors | 2 | 2017 | 208 | 0.29 | Why? |
| Climate | 2 | 2021 | 557 | 0.29 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.27 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.24 | Why? |
| Measles | 3 | 2020 | 608 | 0.23 | Why? |
| Effect Modifier, Epidemiologic | 1 | 2021 | 39 | 0.23 | Why? |
| Immunity, Innate | 2 | 2020 | 6570 | 0.20 | Why? |
| Bacterial Vaccines | 1 | 2021 | 139 | 0.20 | Why? |
| Evolution, Molecular | 4 | 2021 | 3691 | 0.19 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.19 | Why? |
| Sneezing | 1 | 2020 | 173 | 0.19 | Why? |
| Acclimatization | 1 | 2019 | 69 | 0.19 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.19 | Why? |
| Epidemiologic Research Design | 1 | 2020 | 166 | 0.18 | Why? |
| Plant Bark | 1 | 2017 | 39 | 0.17 | Why? |
| Moths | 1 | 2017 | 24 | 0.17 | Why? |
| Bartonella | 1 | 2017 | 24 | 0.17 | Why? |
| Bartonella Infections | 1 | 2017 | 18 | 0.17 | Why? |
| Urbanization | 1 | 2018 | 133 | 0.17 | Why? |
| Rabies | 1 | 2018 | 113 | 0.17 | Why? |
| Spatio-Temporal Analysis | 3 | 2020 | 1182 | 0.17 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2018 | 115 | 0.16 | Why? |
| School Teachers | 1 | 2021 | 345 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Endemic Diseases | 1 | 2020 | 480 | 0.16 | Why? |
| Rodent Diseases | 1 | 2017 | 115 | 0.16 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.16 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Seasons | 4 | 2021 | 4071 | 0.15 | Why? |
| Africa South of the Sahara | 1 | 2021 | 1335 | 0.15 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.15 | Why? |
| Humidity | 2 | 2020 | 944 | 0.15 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.15 | Why? |
| Animals | 8 | 2020 | 78931 | 0.14 | Why? |
| Madagascar | 3 | 2020 | 197 | 0.14 | Why? |
| Africa | 2 | 2021 | 2986 | 0.14 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.14 | Why? |
| Post-Exposure Prophylaxis | 1 | 2018 | 472 | 0.13 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.13 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| History, 21st Century | 1 | 2021 | 1849 | 0.13 | Why? |
| Global Health | 3 | 2021 | 13911 | 0.12 | Why? |
| Computer Simulation | 4 | 2020 | 4982 | 0.12 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.12 | Why? |
| Cell Phone | 1 | 2020 | 750 | 0.12 | Why? |
| Risk Reduction Behavior | 1 | 2020 | 946 | 0.12 | Why? |
| Public Health Practice | 2 | 2020 | 945 | 0.12 | Why? |
| Humans | 34 | 2021 | 930598 | 0.12 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.12 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.11 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.11 | Why? |
| Sex Characteristics | 1 | 2018 | 1120 | 0.10 | Why? |
| Disease Outbreaks | 5 | 2021 | 27595 | 0.10 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.10 | Why? |
| Hand Disinfection | 1 | 2020 | 1671 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.09 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.09 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.08 | Why? |
| United States | 5 | 2021 | 46150 | 0.08 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.08 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Incidence | 5 | 2018 | 25622 | 0.07 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.07 | Why? |
| Schools | 1 | 2021 | 4187 | 0.07 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.07 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.07 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.06 | Why? |
| Disease Susceptibility | 3 | 2021 | 4002 | 0.06 | Why? |
| Students | 1 | 2021 | 5255 | 0.06 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Orthomyxoviridae | 2 | 2020 | 1168 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Strategic Stockpile | 1 | 2021 | 120 | 0.05 | Why? |
| Bayes Theorem | 2 | 2021 | 3237 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Injections, Intradermal | 1 | 2018 | 102 | 0.05 | Why? |
| Zimbabwe | 1 | 2018 | 198 | 0.04 | Why? |
| Behavior | 1 | 2020 | 252 | 0.04 | Why? |
| Aged | 5 | 2021 | 215776 | 0.04 | Why? |
| Adaptation, Physiological | 1 | 2021 | 359 | 0.04 | Why? |
| Female | 6 | 2021 | 380317 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Male | 5 | 2021 | 367725 | 0.04 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.04 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2018 | 800 | 0.04 | Why? |
| Emigration and Immigration | 1 | 2021 | 501 | 0.04 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.04 | Why? |
| Forecasting | 2 | 2020 | 4492 | 0.04 | Why? |
| Kenya | 1 | 2018 | 887 | 0.04 | Why? |
| Rodentia | 1 | 2017 | 235 | 0.04 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.04 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.04 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.03 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.03 | Why? |
| Weather | 1 | 2020 | 581 | 0.03 | Why? |
| Privacy | 1 | 2020 | 636 | 0.03 | Why? |
| Ethiopia | 1 | 2018 | 1222 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2020 | 846 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Population Density | 1 | 2018 | 694 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Mexico | 1 | 2020 | 2787 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Vaccination Refusal | 1 | 2020 | 831 | 0.03 | Why? |
| Antigens, Viral | 2 | 2018 | 6298 | 0.03 | Why? |
| Immune System | 1 | 2021 | 1479 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.02 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Cities | 1 | 2018 | 4937 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Japan | 1 | 2018 | 6653 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
| Vaccines | 1 | 2020 | 3692 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Masks | 1 | 2021 | 8528 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
Metcalf's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(140)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_